Application 021093
- Type
- NDA
- Sponsor
- ANI PHARMS INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ATACAND HCT | CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE | TABLET;ORAL | 16MG;12.5MG | Yes | No |
| 002 | ATACAND HCT | CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE | TABLET;ORAL | 32MG;12.5MG | Yes | No |
| 003 | ATACAND HCT | CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE | TABLET;ORAL | 32MG;25MG | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021093-001 | ATACAND HCT | CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE | 16MG;12.5MG | TABLET / ORAL | AB | RLD | 2000-09-05 |
| N021093-002 | ATACAND HCT | CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE | 32MG;12.5MG | TABLET / ORAL | AB | RLD | 2000-09-05 |
| N021093-003 | ATACAND HCT | CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE | 32MG;25MG | TABLET / ORAL | AB | RLD, RS | 2008-05-16 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N021093-001 | AB |
| N021093-002 | AB |
| N021093-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N021093-001 | ATACAND HCT | 16MG;12.5MG | TABLET / ORAL | AB | RLD | 2000-09-05 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021093-002 | ATACAND HCT | 32MG;12.5MG | TABLET / ORAL | AB | RLD | 2000-09-05 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021093-003 | ATACAND HCT | 32MG;25MG | TABLET / ORAL | AB | RLD, RS | 2008-05-16 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021093-001 | ATACAND HCT | 16MG;12.5MG | TABLET / ORAL | AB | RLD | 2000-09-05 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021093-002 | ATACAND HCT | 32MG;12.5MG | TABLET / ORAL | AB | RLD | 2000-09-05 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021093-003 | ATACAND HCT | 32MG;25MG | TABLET / ORAL | AB | RLD, RS | 2008-05-16 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N021093-001 | ATACAND HCT | 16MG;12.5MG | TABLET / ORAL | AB | RLD | 2000-09-05 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021093-002 | ATACAND HCT | 32MG;12.5MG | TABLET / ORAL | AB | RLD | 2000-09-05 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021093-003 | ATACAND HCT | 32MG;25MG | TABLET / ORAL | AB | RLD, RS | 2008-05-16 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021093-001 | ATACAND HCT | 16MG;12.5MG | TABLET / ORAL | AB | RLD | 2000-09-05 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021093-002 | ATACAND HCT | 32MG;12.5MG | TABLET / ORAL | AB | RLD | 2000-09-05 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021093-003 | ATACAND HCT | 32MG;25MG | TABLET / ORAL | AB | RLD, RS | 2008-05-16 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021093-001 | ATACAND HCT | 16MG;12.5MG | TABLET / ORAL | AB | RLD | 2000-09-05 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021093-002 | ATACAND HCT | 32MG;12.5MG | TABLET / ORAL | AB | RLD | 2000-09-05 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021093-003 | ATACAND HCT | 32MG;25MG | TABLET / ORAL | AB | RLD, RS | 2008-05-16 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021093-001 | ATACAND HCT | 16MG;12.5MG | TABLET / ORAL | AB | RLD | 2000-09-05 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021093-002 | ATACAND HCT | 32MG;12.5MG | TABLET / ORAL | AB | RLD | 2000-09-05 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021093-003 | ATACAND HCT | 32MG;25MG | TABLET / ORAL | AB | RLD, RS | 2008-05-16 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021093-001 | ATACAND HCT | 16MG;12.5MG | TABLET / ORAL | AB | RLD | 2000-09-05 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021093-002 | ATACAND HCT | 32MG;12.5MG | TABLET / ORAL | AB | RLD | 2000-09-05 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021093-003 | ATACAND HCT | 32MG;25MG | TABLET / ORAL | AB | RLD, RS | 2008-05-16 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021093-001 | ATACAND HCT | 16MG;12.5MG | TABLET / ORAL | AB | RLD | 2000-09-05 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021093-002 | ATACAND HCT | 32MG;12.5MG | TABLET / ORAL | AB | RLD | 2000-09-05 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021093-003 | ATACAND HCT | 32MG;25MG | TABLET / ORAL | AB | RLD, RS | 2008-05-16 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021093-001 | ATACAND HCT | 16MG;12.5MG | TABLET / ORAL | AB | RLD | 2000-09-05 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021093-002 | ATACAND HCT | 32MG;12.5MG | TABLET / ORAL | AB | RLD | 2000-09-05 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021093-003 | ATACAND HCT | 32MG;25MG | TABLET / ORAL | AB | RLD, RS | 2008-05-16 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N021093-001 | ATACAND HCT | 16MG;12.5MG | TABLET / ORAL | AB | RLD | 2000-09-05 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N021093-002 | ATACAND HCT | 32MG;12.5MG | TABLET / ORAL | AB | RLD | 2000-09-05 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N021093-003 | ATACAND HCT | 32MG;25MG | TABLET / ORAL | AB | RLD, RS | 2008-05-16 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021093-001 | ATACAND HCT | 16MG;12.5MG | TABLET / ORAL | AB | RLD | 2000-09-05 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021093-002 | ATACAND HCT | 32MG;12.5MG | TABLET / ORAL | AB | RLD | 2000-09-05 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021093-003 | ATACAND HCT | 32MG;25MG | TABLET / ORAL | AB | RLD, RS | 2008-05-16 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021093-001 | ATACAND HCT | 16MG;12.5MG | TABLET / ORAL | AB | RLD | 2000-09-05 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021093-002 | ATACAND HCT | 32MG;12.5MG | TABLET / ORAL | AB | RLD | 2000-09-05 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021093-003 | ATACAND HCT | 32MG;25MG | TABLET / ORAL | AB | RLD, RS | 2008-05-16 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021093-001 | ATACAND HCT | 16MG;12.5MG | TABLET / ORAL | AB | RLD | 2000-09-05 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021093-002 | ATACAND HCT | 32MG;12.5MG | TABLET / ORAL | AB | RLD | 2000-09-05 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021093-003 | ATACAND HCT | 32MG;25MG | TABLET / ORAL | AB | RLD, RS | 2008-05-16 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N021093-001 | ATACAND HCT | 16MG;12.5MG | TABLET / ORAL | AB | RLD | 2000-09-05 | 8072bd15b7f6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N021093-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021093-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N021093-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021093-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021093-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021093-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N021093-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021093-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N021093-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021093-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021093-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021093-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021093-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021093-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021093-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021093-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021093-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021093-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021093-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021093-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021093-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021093-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021093-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021093-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021093-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021093-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021093-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N021093-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N021093-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N021093-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021093-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021093-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021093-003 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021093-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021093-002 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021093-003 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021093-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021093-002 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021093-003 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N021093-001 | AB | 1 | 8072bd15b7f6… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ATACAND HCT | CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE | ANI Pharmaceuticals, Inc. | d91152c4-66ba-466f-b4f9-0da628d42b1d | 2025-12-22 | Boxed warning, Warnings, Adverse reactions | 021093 NDA021093 62559-652 62559-651 62559-650 |
| Candesartan Cilexetil and Hydrochlorothiazide | CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE | ANI Pharmaceuticals, Inc. | bd8d318d-167a-4b26-935d-265dde3193de | 2025-12-22 | Boxed warning, Warnings, Adverse reactions | 021093 NDA021093 62559-660 62559-662 62559-661 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0186-0162 | ATACAND HCT | Candesartan cilexetil and Hydrochlorothiazide | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0186-0322 | ATACAND HCT | Candesartan cilexetil and Hydrochlorothiazide | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 0186-0324 | ATACAND HCT | Candesartan cilexetil Hydrochlorothiazide | AstraZeneca Pharmaceuticals LP | NDA | Current |
| 62559-650 | ATACAND HCT | Candesartan Cilexetil and Hydrochlorothiazide | ANI Pharmaceuticals, Inc. | NDA | Current |
| 62559-650 | ATACAND HCT | Candesartan Cilexetil and Hydrochlorothiazide | ANI Pharmaceuticals, Inc. | NDA | Current |
| 62559-650 | ATACAND HCT | Candesartan Cilexetil and Hydrochlorothiazide | ANI Pharmaceuticals, Inc. | NDA | Current |
| 62559-651 | ATACAND HCT | Candesartan Cilexetil and Hydrochlorothiazide | ANI Pharmaceuticals, Inc. | NDA | Current |
| 62559-651 | ATACAND HCT | Candesartan Cilexetil and Hydrochlorothiazide | ANI Pharmaceuticals, Inc. | NDA | Current |
| 62559-651 | ATACAND HCT | Candesartan Cilexetil and Hydrochlorothiazide | ANI Pharmaceuticals, Inc. | NDA | Current |
| 62559-652 | ATACAND HCT | Candesartan Cilexetil and Hydrochlorothiazide | ANI Pharmaceuticals, Inc. | NDA | Current |
| 62559-652 | ATACAND HCT | Candesartan Cilexetil and Hydrochlorothiazide | ANI Pharmaceuticals, Inc. | NDA | Current |
| 62559-652 | ATACAND HCT | Candesartan Cilexetil and Hydrochlorothiazide | ANI Pharmaceuticals, Inc. | NDA | Current |
| 62559-660 | Candesartan Cilexetil and Hydrochlorothiazide | Candesartan Cilexetil and Hydrochlorothiazide | ANI Pharmaceuticals, Inc. | NDA AUTHORIZED GENERIC | Current |
| 62559-660 | Candesartan Cilexetil and Hydrochlorothiazide | Candesartan Cilexetil and Hydrochlorothiazide | ANI Pharmaceuticals, Inc. | NDA AUTHORIZED GENERIC | Current |
| 62559-660 | Candesartan Cilexetil and Hydrochlorothiazide | Candesartan Cilexetil and Hydrochlorothiazide | ANI Pharmaceuticals, Inc. | NDA AUTHORIZED GENERIC | Current |
| 62559-661 | Candesartan Cilexetil and Hydrochlorothiazide | Candesartan Cilexetil and Hydrochlorothiazide | ANI Pharmaceuticals, Inc. | NDA AUTHORIZED GENERIC | Current |
| 62559-661 | Candesartan Cilexetil and Hydrochlorothiazide | Candesartan Cilexetil and Hydrochlorothiazide | ANI Pharmaceuticals, Inc. | NDA AUTHORIZED GENERIC | Current |
| 62559-661 | Candesartan Cilexetil and Hydrochlorothiazide | Candesartan Cilexetil and Hydrochlorothiazide | ANI Pharmaceuticals, Inc. | NDA AUTHORIZED GENERIC | Current |
| 62559-662 | Candesartan Cilexetil and Hydrochlorothiazide | Candesartan Cilexetil and Hydrochlorothiazide | ANI Pharmaceuticals, Inc. | NDA AUTHORIZED GENERIC | Current |
| 62559-662 | Candesartan Cilexetil and Hydrochlorothiazide | Candesartan Cilexetil and Hydrochlorothiazide | ANI Pharmaceuticals, Inc. | NDA AUTHORIZED GENERIC | Current |
| 62559-662 | Candesartan Cilexetil and Hydrochlorothiazide | Candesartan Cilexetil and Hydrochlorothiazide | ANI Pharmaceuticals, Inc. | NDA AUTHORIZED GENERIC | Current |
| 63629-3377 | ATACAND HCT | Candesartan cilexetil and Hydrochlorothiazide | Bryant Ranch Prepack | NDA | Current |
| 63629-3377 | ATACAND HCT | Candesartan cilexetil and Hydrochlorothiazide | Bryant Ranch Prepack | NDA | Current |
| 70518-2720 | Candesartan Cilexetil and Hydrochlorothiazide | Candesartan Cilexetil and Hydrochlorothiazide | REMEDYREPACK INC. | NDA AUTHORIZED GENERIC | Current |
| 70518-2720 | Candesartan Cilexetil and Hydrochlorothiazide | Candesartan Cilexetil and Hydrochlorothiazide | REMEDYREPACK INC. | NDA AUTHORIZED GENERIC | Current |
| 70518-2720 | Candesartan Cilexetil and Hydrochlorothiazide | Candesartan Cilexetil and Hydrochlorothiazide | REMEDYREPACK INC. | NDA AUTHORIZED GENERIC | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 64429 | SUPPL | 2020-08-27 |
| 64381 | SUPPL | 2020-08-24 |
| 14381 | SUPPL | 2016-03-04 |
| 4322 | SUPPL | 2016-02-11 |
| 14380 | SUPPL | 2015-02-10 |
| 4320 | SUPPL | 2015-02-10 |
| 4321 | SUPPL | 2013-04-30 |
| 36107 | SUPPL | 2013-04-29 |
| 4319 | SUPPL | 2012-04-02 |
| 36106 | SUPPL | 2012-03-29 |
| 44096 | ORIG | 2011-12-22 |
| 4318 | SUPPL | 2011-06-17 |
| 36105 | SUPPL | 2011-06-16 |
| 4317 | SUPPL | 2011-03-16 |
| 14379 | SUPPL | 2011-03-11 |
| 26758 | SUPPL | 2008-05-20 |
| 26757 | SUPPL | 2006-08-18 |
| 14378 | SUPPL | 2006-08-18 |
| 4316 | SUPPL | 2004-12-30 |
| 21446 | ORIG | 2004-05-27 |
| 26756 | ORIG | 2000-09-05 |
| 14377 | ORIG | 2000-09-05 |